Home › Funds › KANAWHA CAPITAL MANAGEMENT LLC › ABT

KANAWHA CAPITAL MANAGEMENT LLC position in ABT

ABBOTT LABORATORIES · Health Care

KANAWHA CAPITAL MANAGEMENT LLC reported holding 199,671 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$19.7M, representing 1.26% of its reported portfolio and ranking #26 among its reported holdings. KANAWHA CAPITAL MANAGEMENT LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)199.67K sh
Reported value held$19.73M
Portfolio Weight1.26%
First reportedQ3 2023
Last changeAdd
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How KANAWHA CAPITAL MANAGEMENT LLC's ABT position evolved

KANAWHA CAPITAL MANAGEMENT LLC first disclosed a stake in ABT in Q3 2023 at 182,784 shares (US$17.7M). The position peaked in Q2 2025 at 177,363 shares, worth US$24.1M. Across 13 filings, KANAWHA CAPITAL MANAGEMENT LLC increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 199,671 shares valued at US$19.7M — an increase of 3,995 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 182.78K $17.70M New
Q4 2023 174.69K $19.23M Reduce
Q1 2024 177.83K $20.21M Add
Q2 2024 186.17K $19.35M Add
Q3 2024 177.53K $20.24M Reduce
Q4 2024 177.64K $20.09M Hold
Q1 2025 177.76K $23.58M Hold
Q2 2025 177.36K $24.12M Hold
Q3 2025 176.26K $23.61M Reduce
Q4 2025 179.35K $22.47M Add
Q1 2026 182.28K $18.72M Add
Q2 2026 195.68K $17.76M Add
Q3 2026 199.67K $19.73M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has KANAWHA CAPITAL MANAGEMENT LLC held ABT?

KANAWHA CAPITAL MANAGEMENT LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is KANAWHA CAPITAL MANAGEMENT LLC's current position in ABT?

As of Q3 2026, KANAWHA CAPITAL MANAGEMENT LLC holds 199.67K shares of ABT (ABBOTT LABORATORIES), valued at $19.73M, representing 1.26% of its reported portfolio and ranking #26.

Has KANAWHA CAPITAL MANAGEMENT LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), KANAWHA CAPITAL MANAGEMENT LLC increased its position in ABT. The position peaked in Q2 2025 at 177.36K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.